Citation Impact
Citing Papers
Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update
2011 Standout
Professional interpreters and bilingual physicians in a pediatric emergency department: effect on resource utilization.
2002
Implications of Coronary Artery Calcium Testing for Treatment Decisions Among Statin Candidates According to the ACC/AHA Cholesterol Management Guidelines
2017
Subjective assessments of comorbidity correlate with quality of life health outcomes: Initial validation of a comorbidity assessment instrument
2005
Cancer statistics, 2024
2024 Standout
Crossing The Language Chasm
2005
Is silence golden? A test of the incorporation of the effects of ill‐health on income and leisure in health state valuations
2005
High-Value, Cost-Conscious Health Care: Concepts for Clinicians to Evaluate the Benefits, Harms, and Costs of Medical Interventions
2011
In or Out? Income Losses in Health State Valuations: A Review
2009
Effects of Care Coordination on Hospitalization, Quality of Care, and Health Care Expenditures Among Medicare Beneficiaries
2009
The Response of Drug Expenditure to Nonlinear Contract Design: Evidence from Medicare Part D *
2015
Processes of care desired by elderly patients with multimorbidities
2008
Antithrombotic Therapy for VTE Disease
2016 Standout
Updating and Validating the Charlson Comorbidity Index and Score for Risk Adjustment in Hospital Discharge Abstracts Using Data From 6 Countries
2011 Standout
Disparities in Health Care by Race, Ethnicity, and Language Among the Insured
2002 Standout
A Health Policy Model of CKD: 2. The Cost-Effectiveness of Microalbuminuria Screening
2010
Productivity in pharmaceutical–biotechnology R&D: the role of experience and alliances
2005
Should we aggregate relative or absolute changes in QALYs?
2001
Future costs in cost effectiveness analysis
2008
Evaluating Electronic Referrals for Specialty Care at a Public Hospital
2010 Standout
Rehospitalizations among Patients in the Medicare Fee-for-Service Program
2009 Standout
Job characteristics, satisfaction, and burnout across hospitalist practice models
2012
Racial and Ethnic Disparities in the Receipt of Cancer Treatment
2002
Productivity Costs in Health-State Valuations
2006
Comparison Friction: Experimental Evidence from Medicare Drug Plans
2012
A Cost-Utility Analysis of Lung Cancer Screening and the Additional Benefits of Incorporating Smoking Cessation Interventions
2013
Chronic kidney disease
2011 Standout
Lung cancer: current therapies and new targeted treatments
2016 Standout
Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study
2012 Standout
Antithrombotic Therapy for VTE Disease
2012 Standout
How to improve R&D productivity: the pharmaceutical industry's grand challenge
2010 Standout
Willingness to Pay for a Quality-adjusted Life Year
2000
Association of Communication Between Hospital-based Physicians and Primary Care Providers with Patient Outcomes
2008
Fondaparinux for Isolated Superficial Vein Thrombosis of the Legs
2011
QALY and Productivity Loss: Empirical Evidence for “Double Counting”
2013
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
Gout
2016 Standout
Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold
2008
Deficits in Communication and Information Transfer Between Hospital-Based and Primary Care Physicians
2007 Standout
Chronic kidney disease: global dimension and perspectives
2013 Standout
Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: A Societal Perspective: The ISPOR Drug Cost Task Force Report—Part II
2009
The eHealth Enhanced Chronic Care Model: A Theory Derivation Approach
2015
eReferral — A New Model for Integrated Care
2013 Standout
Costing and Perspective in Published Cost-Effectiveness Analysis
2009
Too Much Ado about Instrumental Variable Approach: Is the Cure Worse than the Disease?
2009
The language divide
2004
Depression, chronic diseases, and decrements in health: results from the World Health Surveys
2007 Standout
Warfarin Use Associates with Increased Risk for Stroke in Hemodialysis Patients with Atrial Fibrillation
2009
Updating Cost-Effectiveness — The Curious Resilience of the $50,000-per-QALY Threshold
2014 Standout
A Systematic Review and Meta-Analysis of Utility-Based Quality of Life in Chronic Kidney Disease Treatments
2012
Clinical development success rates for investigational drugs
2014 Standout
Do Professional Interpreters Improve Clinical Care for Patients with Limited English Proficiency? A Systematic Review of the Literature
2006 Standout
Chronic Kidney Disease
2016 Standout
Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study
2006 Standout
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
2011 Standout
Asymmetric Growth and Institutions in an Interdependent World
2017 StandoutNobel
Did Medicare Induce Pharmaceutical Innovation?
2006 StandoutNobel
Recent Developments in the Econometrics of Program Evaluation
2009 StandoutNobel
Demographics and Automation
2021 StandoutNobel
Exercise and Physical Activity for Older Adults
2009 Standout
Errors in Medical Interpretation and Their Potential Clinical Consequences in Pediatric Encounters
2003
Carbon Taxes, Path Dependency, and Directed Technical Change: Evidence from the Auto Industry
2016 StandoutNobel
Market Size in Innovation: Theory and Evidence from the Pharmaceutical Industry
2004 StandoutNobel
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Prevalence of Burnout Among Physicians
2018 Standout
The Economic Burden of Racial, Ethnic, and Educational Health Inequities in the US
2023
Overcoming Language Barriers in Health Care: Costs and Benefits of Interpreter Services
2004
Systems to rate the strength of scientific evidence.
2002
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2018 Standout
Inequality at Work: The Effect of Peer Salaries on Job Satisfaction
2012 StandoutNobel
Pharmaceuticals and the Developing World
2002 StandoutNobel
ERC: A Theory of Equity, Reciprocity, and Competition
2000 Standout
The Need for More Research on Language Barriers in Health Care: A Proposed Research Agenda
2006
Machine Learning in Medicine
2019 Standout
Cost-Effectiveness of Allopurinol and Febuxostat for the Management of Gout
2014
Sampling‐Based versus Design‐Based Uncertainty in Regression Analysis
2020 StandoutNobel
Good research practices for measuring drug costs in cost-effectiveness analyses: a societal perspective: the ISPOR Drug Cost Task Force report--Part II.
2010
Improving communication between physicians and patients who speak a foreign language.
2003
Patient Safety Concerns Arising from Test Results That Return after Hospital Discharge
2005
Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses
2016 Standout
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
The Impact of Medical Interpreter Services on the Quality of Health Care: A Systematic Review
2005 Standout
Effects of limited English proficiency and physician language on health care comprehension
2005 Standout
Dynamic capabilities: what are they?
2000 Standout
The Economist as Plumber
2017 StandoutNobel
Processes for Effective Communication in Primary Care
2005
American Society of Clinical Oncology Guidance Statement: The Cost of Cancer Care
2009
Market Power Screens Willingness-to-Pay*
2012 StandoutNobel
Corporate reputation and sustained superior financial performance
2002 Standout
Preventives Versus Treatments *
2015 StandoutNobel
Pharmaceutical Development Phases: A Duration Analysis
2004
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Product innovation, product-market competition and persistent profitability in the U.S. pharmaceutical industry
1999
Works of David Meltzer being referenced
Patterns of prostate cancer treatment by clinical stage and age
2001
A Text Messaging Intervention to Improve Heart Failure Self-Management After Hospital Discharge in a Largely African-American Population: Before-After Study
2013
Illustrating the impact of including future costs in economic evaluations: an application to end‐stage renal disease care
2003
Effect of Future Costs on Cost-Effectiveness of Medical Interventions Among Young Adults
2000
Barriers to patient-physician communication about out-of-pocket costs
2004
Use of a Self-Report-Generated Charlson Comorbidity Index for Predicting Mortality
2005
Does Doctor–Patient Communication Affect Patient Satisfaction with Hospital Care? Results of an Analysis with a Novel Instrumental Variable
2008
What Does the Value of Modern Medicine Say About the $50,000 per Quality-Adjusted Life-Year Decision Rule?
2008
Impact of interpreter services on delivery of health care to limited-English-proficient patients
2001
Inconsistencies in the "Societal Perspective" on Costs of the Panel on Cost-Effectiveness in Health and Medicine
1999
The Effect of the Medicare Part D Prescription Benefit on Drug Utilization and Expenditures
2008
Measuring the Cost of Quality Measurement
2017
Coordinating Care across Diseases, Settings, and Clinicians: A Key Role for the Generalist in Practice
2005
Do Important Drugs Reach the Market Sooner?
1994
Effects of Physician Experience on Costs and Outcomes on an Academic General Medicine Service: Results of a Trial of Hospitalists
2002
Future Costs, Fixed Healthcare Budgets, and the Decision Rules of Cost‐Effectiveness Analysis
2014